中国女性乳腺癌患者绝经生殖泌尿综合征管理专家共识(2024年版)

Chinese expert consensus recommendations for management of genitourinary syndrome of menopause in women with breast cancer(version 2024)

绝经生殖泌尿综合征(genitourinary syndrome of menopause,GSM)在乳腺癌患者中的发生比例高,但缺乏及时、有效的诊治,严重影响患者的生活质量和预后。随着乳腺癌患者生存率的提高,肿瘤诊疗步入慢病化管理的时代,而目前国内尚缺乏针对乳腺癌患者GSM管理的针对性指南或共识。故中国医师协会外科医师分会乳腺外科专家工作组、中国抗癌协会肿瘤临床研究管理学专业委员会、国家肿瘤质控中心乳腺癌专家委员会、中国抗癌协会乳腺肿瘤整合康复专业委员会、重庆市临床医学研究联合会、重庆抗癌协会肿瘤内分泌专业委员会、重庆市医学会妇产科学专业委员会重庆市性学会、重庆市医学会泌尿外科专委会和重庆市妇幼卫生学会联合组织相关专家,基于国内外指南、共识及多个中心的临床经验,深入探讨并制定了《中国女性乳腺癌患者绝经生殖泌尿综合征管理专家共识(2024年版)》,旨在为我国女性乳腺癌患者GSM的规范化管理提供参考。

Genitourinary syndrome of menopause(GSM)is more prevalent among breast cancer patients,with a notable absence of timely and effective diagnosis and treatment,severely impacting patients'quality of life and prognosis.With the improved survival rates of breast cancer patients,the management of cancer has entered an era of chronic disease management.However,there is still a lack of targeted guidelines or consensus for the management of GSM in women with breast cancer in China.Based on the guideline/expert consensus and the clinical experience of multiple medical centers,Breast Surgery Expert Working Group of Surgeons Branch of Chinese Medical Doctor Association,the Society of Clinical Cancer Research Administration of China Anti-Cancer Association,the Breast Cancer Expert Committee of the National Cancer Quality Control Center,Breast Cancer Rehabilitation Committee of China Anti-Cancer Association,Chongqing Federation of Clinical Medical Research,the Society of Onco-endocrinology of Chongqing Anti-Cancer Association,Obstetrics and Gynecology Committee of Chongqing Medical Association,Chongqing Sexology Association,Committee of Urology of Chongqing Medical Association,and Chongqing Maternal and Child Health Association thoroughly discussed and formulated the Chinese expert consensus recommendations for management of genitourinary syndrome of menopause in women with breast cancer(version 2024),in order to further standardize the management of GSM in breast cancer patients.